Mon Mar 26, 2012 3:57am EDT
March 26 (Reuters) - U.S. clinical research firm Contract Research Solutions Inc, also known as Cetero, filed for bankruptcy protection early on Monday, court filings show.
The company has listed estimated liabilities of $100 million to $500 million and assets of $1 million to $10 million, according to court documents.
Contract research organizations (CROs) like Cetero provide outsourced drug research services to pharmaceutical and biotechnology firms.
The case is: Contract Research Solutions Inc, Case No. 12-11004, U.S. Bankruptcy Court, District of Delaware.
0 comments:
Post a Comment